Makoto Emoto

1.5k total citations
55 papers, 1.1k citations indexed

About

Makoto Emoto is a scholar working on Molecular Biology, Obstetrics and Gynecology and Reproductive Medicine. According to data from OpenAlex, Makoto Emoto has authored 55 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 21 papers in Obstetrics and Gynecology and 14 papers in Reproductive Medicine. Recurrent topics in Makoto Emoto's work include Angiogenesis and VEGF in Cancer (18 papers), Uterine Myomas and Treatments (16 papers) and Ovarian cancer diagnosis and treatment (12 papers). Makoto Emoto is often cited by papers focused on Angiogenesis and VEGF in Cancer (18 papers), Uterine Myomas and Treatments (16 papers) and Ovarian cancer diagnosis and treatment (12 papers). Makoto Emoto collaborates with scholars based in Japan, United Kingdom and Brazil. Makoto Emoto's co-authors include Tatsuhiko Kawarabayashi, Hiroshi Iwasaki, Masahiro Kikuchi, Toru Hachisuga, K Shirakawa, Fuyuki Eguchi, S. Horiuchi, Masako Ishiguro, D. Stephen Charnock‐Jones and S. K. Smith and has published in prestigious journals such as Biomaterials, Cancer and Annals of the New York Academy of Sciences.

In The Last Decade

Makoto Emoto

52 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Makoto Emoto Japan 19 428 388 361 316 150 55 1.1k
Dong Soo Suh South Korea 19 376 0.9× 217 0.6× 273 0.8× 435 1.4× 140 0.9× 80 1.2k
Iori Kisu Japan 26 448 1.0× 277 0.7× 207 0.6× 335 1.1× 103 0.7× 89 1.7k
Mark Messing United States 13 261 0.6× 306 0.8× 478 1.3× 420 1.3× 171 1.1× 31 1.1k
Yoko Harima Japan 17 359 0.8× 267 0.7× 115 0.3× 219 0.7× 104 0.7× 42 1.0k
Kenji Umayahara Japan 16 164 0.4× 404 1.0× 287 0.8× 129 0.4× 119 0.8× 41 828
Mary Cunningham United States 15 161 0.4× 212 0.5× 151 0.4× 164 0.5× 107 0.7× 26 804
Ruthy Shaco‐Levy Israel 19 207 0.5× 190 0.5× 315 0.9× 214 0.7× 123 0.8× 57 1.2k
Kurosh Rahimi Canada 17 312 0.7× 126 0.3× 271 0.8× 384 1.2× 125 0.8× 46 1.0k
P Maxwell United Kingdom 22 431 1.0× 289 0.7× 296 0.8× 451 1.4× 274 1.8× 40 1.5k
Cono Scaffa Italy 21 152 0.4× 614 1.6× 592 1.6× 157 0.5× 102 0.7× 70 1.2k

Countries citing papers authored by Makoto Emoto

Since Specialization
Citations

This map shows the geographic impact of Makoto Emoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Makoto Emoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Makoto Emoto more than expected).

Fields of papers citing papers by Makoto Emoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Makoto Emoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Makoto Emoto. The network helps show where Makoto Emoto may publish in the future.

Co-authorship network of co-authors of Makoto Emoto

This figure shows the co-authorship network connecting the top 25 collaborators of Makoto Emoto. A scholar is included among the top collaborators of Makoto Emoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Makoto Emoto. Makoto Emoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Emoto, Makoto, et al.. (2015). Advanced Chemoembolization by Anti-angiogenic Calcium-Phosphate Ceramic Microspheres Targeting the Vascular Heterogeneity of Cancer Xenografts.. PubMed. 35(9). 4757–64. 1 indexed citations
2.
3.
4.
5.
Kawarabayashi, Tatsuhiko, et al.. (2010). Metronomic irinotecan chemotherapy combined with ultrasound irradiation for a human uterine sarcoma xenograft. Cancer Science. 102(2). 452–459. 9 indexed citations
6.
Emoto, Makoto, et al.. (2010). Primary leiomyosarcoma of the fallopian tube. International Journal of Clinical Oncology. 15(2). 206–209. 3 indexed citations
7.
Negishi, Yoichi, Nobuhito Hamano, Yoko Endo, et al.. (2009). Ultrasound Imaging and Gene Delivery by AG73-modified Bubble Liposomes. Biopolymers. 2008. 127–130. 1 indexed citations
8.
Hachisuga, Toru, et al.. (2009). Endometrial Cytologic Findings in Tamoxifen-Treated Breast Cancer Patients. Acta Cytologica. 53(1). 24–28. 5 indexed citations
9.
Emoto, Makoto, et al.. (2009). Novel chemoembolization using calcium‐phosphate ceramic microsphere incorporating TNP‐470, an anti‐angiogenic agent. Cancer Science. 101(4). 984–990. 8 indexed citations
10.
Emoto, Makoto, Katsuro Tachibana, Hiroshi Iwasaki, & Tatsuhiko Kawarabayashi. (2007). Antitumor effect of TNP‐470, an angiogenesis inhibitor, combined with ultrasound irradiation for human uterine sarcoma xenografts evaluated using contrast color Doppler ultrasound. Cancer Science. 98(6). 929–935. 16 indexed citations
11.
Hachisuga, Toru, et al.. (2005). K-ras mutation in the endometrium of tamoxifen-treated breast cancer patients, with a comparison of tamoxifen and toremifene. British Journal of Cancer. 92(6). 1098–1103. 18 indexed citations
12.
Emoto, Makoto, Masako Ishiguro, Hiroshi Iwasaki, Masahiro Kikuchi, & Tatsuhiko Kawarabayashi. (2003). Effect of angiogenesis inhibitor TNP-470 on the growth, blood flow, and microvessel density in xenografts of human uterine carcinosarcoma in nude mice. Gynecologic Oncology. 89(1). 88–94. 14 indexed citations
13.
Yokoyama, Yoshihito, D. Stephen Charnock‐Jones, D Licence, et al.. (2003). Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma. British Journal of Cancer. 88(2). 237–244. 129 indexed citations
14.
Emoto, Makoto, et al.. (2000). TNP-470 inhibits growth and the production of vascular endothelial growth factor of uterine carcinosarcoma cells in vitro.. PubMed. 20(1C). 601–4. 15 indexed citations
15.
Hachisuga, Toru, Tsunehisa Kaku, Fuyuki Eguchi, et al.. (1999). The grading of lymphovascular space invasion in endometrial carcinoma. Cancer. 86(10). 2090–2097. 61 indexed citations
16.
Emoto, Makoto, et al.. (1998). The Blood Flow Characteristics in Borderline Ovarian Tumors Based on Both Color Doppler Ultrasound and Histopathological Analyses. Gynecologic Oncology. 70(3). 351–357. 31 indexed citations
17.
18.
Emoto, Makoto, Hiroshi Iwasaki, Masahiro Kikuchi, & K Shirakawa. (1996). Tissue Polypeptide Antigen Production in a Uterine Carcinosarcoma Cell Line in a Serum-Free Culture. Gynecologic Oncology. 60(3). 443–449. 4 indexed citations
19.
Emoto, Makoto, et al.. (1994). Primary Osteosarcoma of the Uterus: Report of a Case with Immunohistochemical Analysis. Gynecologic Oncology. 54(3). 385–388. 14 indexed citations
20.
Emoto, Makoto, Hiroshi Iwasaki, Masahiro Kikuchi, & K Shirakawa. (1993). Characteristics of cloned cells of mixed müllerian tumor of the human uterus carcinoma cells showing myogenic differentiation in vitro. Cancer. 71(10). 3065–3075. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dong Soo Suh Breakdown of academic impact, for papers by Iori Kisu Breakdown of academic impact, for papers by Mark Messing Breakdown of academic impact, for papers by Yoko Harima Breakdown of academic impact, for papers by Kenji Umayahara Breakdown of academic impact, for papers by Mary Cunningham Breakdown of academic impact, for papers by Ruthy Shaco‐Levy Breakdown of academic impact, for papers by Kurosh Rahimi Breakdown of academic impact, for papers by P Maxwell Breakdown of academic impact, for papers by Cono Scaffa
Rankless by CCL
2026